×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| BERYL DRUGS LTD. | NA | NA | NA | NA | 11.4 | 49.4 |
| GENOMIC VALLEY BIOTECH LIMITED | NA | NA | NA | NA | 11 | 44.0 |
| Cian Healthcare Limited | NA | NA | NA | NA | 10.3 |
Beryl Drugs Ltd., with Security Code 524606, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.2 | 6.1 | 8.1 | 8.0 | 7.6 | 3.0 | 6.2 | 5.6 | 5.3 | 4.0 |
| Expenses | 7.5 | 5.8 | 7.0 | 7.4 | 6.9 | 3.2 | 5.3 | 5.1 | 4.8 | 4.7 |
| Operating Profit | 0.7 | 0.3 | 1.1 | 0.7 | 0.8 | -0.2 | 0.9 | 0.5 | 0.5 | -0.7 |
| OPM % | 8.33% | 4.76% | 13.16% | 8.2% | 9.97% | -6.92% | 15.15% | 9.51% | 9.42% | -18.37% |
| Other Income | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.2 | 0.0 | 0.0 | 0.1 | 1.2 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Profit before tax | 0.4 | 0.1 | 0.7 | 0.3 | 0.4 | -0.4 | 0.5 | 0.1 | 0.2 | 0.1 |
| Tax % | -62.2% | 5% | -27.4% | -16% | -17.3% | -18% | -25.8% | -93.5% | -67.1% | 0% |
| Net Profit | 0.1 | 0.1 | 0.5 | 0.3 | 0.3 | -0.3 | 0.4 | 0.0 | 0.1 | 0.2 |
| EPS in Rs | 0.28 | 0.12 | 1.05 | 0.54 | 0.61 | -0.68 | 0.73 | 0.01 | 0.1 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 16% |
| 3 Years: | 24% |
| TTM: | -32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 6% |
| 3 Years: | 113% |
| TTM: | -93% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 37% |
| 3 Years: | 34% |
| 1 Year: | -47% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|